Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants
        Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.        
                  Brain.                
                  2023,
                
                          
                                  
                  ISSN: 0006-8950,
                
                
                              PMID: 37243427,                          
                
                          
        
      
    